What is Arathi Goldsmith's NPI number?

Arathi Goldsmith's National Provider Identifier (NPI) is 1437387404, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Arathi Goldsmith's specialty?

Arathi Goldsmith is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Arathi Goldsmith located?

Arathi Goldsmith's practice location on file with NPPES is 835 Mason St Ste C200, Dearborn, MI 48124-2231.

What is Arathi Goldsmith's phone number?

The practice phone number listed in the NPPES registry for Arathi Goldsmith is (313) 274-5810.

Does Arathi Goldsmith accept Medicare?

Arathi Goldsmith is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Arathi Goldsmith's NPI active?

Yes — Arathi Goldsmith's NPI (1437387404) is active in the NPPES registry as of the last update on 2018-03-17.

IndividualActiveAccepts Medicare

Arathi Goldsmith, DO

NPI 1437387404 · Dermatology Physician · Dearborn, MI

Arathi Goldsmith, DO is a Dermatology Physician provider in Dearborn, MI (NPI 1437387404).

Provider details

NPI number: 1437387404
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: DO
Sex: Female
Sole proprietor: No
License: AG018507 (MI)

Practice location

835 Mason St Ste C200

Dearborn, MI 48124-2231

Phone: (313) 274-5810

Fax: (313) 274-1499

Street-level locationGet directions

More MI providers

Mailing address

835 Mason St

Dearborn, MI 48124

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense AG018507 (MI)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

18550 Outer Dr
Dearborn, MI 48128-1872
Phone: (313) 274-5810
Fax: (313) 274-1499

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(78/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
17 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
2,858 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	795	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	669	$97
Destruction of Precancer Skin Growth, 1 Growth17000	270	$57
Destruction of Skin Growth, 1-14 Growths17110	264	$118
Biopsy of Related Skin Growth, First Growth11102	217	$97
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	252	151
Clobetasol Propionate	231	154
Hydrocortisone	137	118
Triamcinolone Acetonide	126	108
Ammonium Lactate	117	94
Doxycycline Hyclate	112	62
Mupirocin	104	92
Cephalexin	65	56

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,220 across 81 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2009-06-29
Last updated: 2018-03-17

Frequently asked questions

What is Arathi Goldsmith's NPI number?: Arathi Goldsmith's National Provider Identifier (NPI) is 1437387404, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Arathi Goldsmith's specialty?: Arathi Goldsmith is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Arathi Goldsmith located?: Arathi Goldsmith's practice location on file with NPPES is 835 Mason St Ste C200, Dearborn, MI 48124-2231.
What is Arathi Goldsmith's phone number?: The practice phone number listed in the NPPES registry for Arathi Goldsmith is (313) 274-5810.
Does Arathi Goldsmith accept Medicare?: Arathi Goldsmith is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Arathi Goldsmith's NPI active?: Yes — Arathi Goldsmith's NPI (1437387404) is active in the NPPES registry as of the last update on 2018-03-17.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	795	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	669	$97
Destruction of Precancer Skin Growth, 1 Growth17000	270	$57
Destruction of Skin Growth, 1-14 Growths17110	264	$118
Biopsy of Related Skin Growth, First Growth11102	217	$97
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

252

151

Clobetasol Propionate

231

154

Hydrocortisone

137

118

Triamcinolone Acetonide

126

108

Ammonium Lactate

117

Doxycycline Hyclate

112

Mupirocin

104

Cephalexin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,220 across 81 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments